Insulet Corp
PODDHealthcare·Medical Devices·USA·Large·NASD·Nov 11 • 10:00 AM ET
147.18-0.88 (-0.60%)
2026-11-11 16:00 CET
Market cap
10,271.07 USD m
Revenue, TTM
3,189.20 USD m
Net income, TTM
428.80 USD m
Free cash flow, TTM
260.00 USD m
EPS diluted, TTM
5.83
P/E
25.22
Price
PODD against its 20, 50 and 200-day averages2050200beatmiss
58.5% under 354.88 on 20 Nov 2025. Last 15 sessions, 18.2% high to low
Profile
PODD52-week range, 9% of the way up
126.4354.88
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
| Index | S&P 500, RUI |
|---|---|
| Employees | 5400 |
| IPO | May 15, 2007 |
| Beta | 1.05 |
| ATR, 14d | 6.15 |
| Rel volume | 0.29 |
| Short float | 7.71% |
| Insider own | 0.44% |
| Inst own | 100.94% |
Snapshot
6 groupsValuation
| Index | S&P 500, RUI |
|---|---|
| Market Cap | 10.21B |
| Enterprise Value | 10.59B |
| Income | 428.80M |
| Sales | 3.19B |
| Book/sh | 22.76 |
| Cash/sh | 8.42 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | 0.00% |
| Employees | 5400 |
| IPO | May 15, 2007 |
Ratios
| P/E | 25.22 |
|---|---|
| Forward P/E | 18.37 |
| PEG | 0.76 |
| P/S | 3.20 |
| P/B | 6.47 |
| P/C | 17.47 |
| P/FCF | 39.27 |
| EV/EBITDA | 14.73 |
| EV/Sales | 3.32 |
| Quick Ratio | 1.79 |
| Current Ratio | 2.47 |
| Debt/Eq | 0.61 |
| LT Debt/Eq | 0.60 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | 5.83 |
|---|---|
| EPS next Y | 8.01 |
| EPS next Q | 1.76 |
| EPS this Y | 37.01% |
| EPS next Y | 17.69% |
| EPS next 5Y | 24.20% |
| EPS past 3/5Y | 275.33% 102.14% |
| Sales past 3/5Y | 27.54% 24.53% |
| EPS Y/Y TTM | 75.56% |
| Sales Y/Y TTM | 26.46% |
| EPS Q/Q | 63.78% |
| Sales Q/Q | 19.21% |
| Earnings | Nov 04 BMO |
| EPS/Sales Surpr. | 25.40% 1.13% |
Ownership
| Insider Own | 0.44% |
|---|---|
| Insider Trans | 2.32% |
| Inst Own | 100.94% |
| Inst Trans | -2.61% |
| ROA | 13.31% |
| ROE | 28.94% |
| ROIC | 17.00% |
| Gross Margin | 72.93% |
| Oper. Margin | 18.42% |
| Profit Margin | 13.45% |
| SMA20 | -1.05% |
| SMA50 | 3.63% |
| SMA200 | -15.29% |
| Trades | - |
Technical
| Shs Outstand | 69.37M |
|---|---|
| Shs Float | 69.07M |
| Short Float | 7.71% |
| Short Ratio | 3.36 |
| Short Interest | 5.33M |
| 52W High | 354.88 -58.53% |
| 52W Low | 126.40 16.44% |
| Volatility | 7.29% 4.07% |
| ATR (14) | 6.15 |
| RSI (14) | 50.06 |
| Beta | 1.05 |
| Rel Volume | 0.29 |
| Avg Volume | 1.58M |
| Volume | 55,673 |
Performance
| Perf Week | -10.81% |
|---|---|
| Perf Month | 6.55% |
| Perf Quarter | 0.50% |
| Perf Half Y | -1.12% |
| Perf YTD | -48.22% |
| Perf Year | -54.89% |
| Perf 3Y | -5.11% |
| Perf 5Y | -53.22% |
| Perf 10Y | 314.34% |
| Recom | 2.07 |
| Target Price | 177.59 |
| Prev Close | 148.06 |
| Price | 147.18 |
| Change % | -0.60% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Oct 07, 2026 | Initiated | BBarclays | Equal Weight | $150 | +1.9% |
| Aug 06, 2026 | Downgrade | WWells Fargo | Overweight → Equal Weight | $144 | -2.2% |
| Aug 06, 2026 | Downgrade | TTruist | Buy → Hold | $153 | +4.0% |
| Aug 06, 2026 | Downgrade | LLeerink Partners | Outperform → Market Perform | $145 | -1.5% |
| Aug 06, 2026 | Downgrade | JJP Morgan | Overweight → Neutral | $152 | +3.3% |
| Aug 06, 2026 | Downgrade | BBTIG Research | Buy → Neutral | ||
| Aug 05, 2026 | Downgrade | OOppenheimer | Outperform → Perform | ||
| Jul 28, 2026 | Resumed | UUBS | Neutral | $174 | +18.2% |
| Jun 23, 2026 | Initiated | DDeutsche Bank | Buy | $190 | +29.1% |
| May 20, 2026 | Resumed | WWilliam Blair | Outperform |
Peers
Mkt capInsider trading
12 filings| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| McEvoy Ashley | President and CEO | Aug 21 '26 | Buy | 147.47 | 1,100 | 162,217 | 23,731 | Aug 24 07:08 AM |
| STONESIFER TIMOTHY C. | Director | Jun 03 '26 | Buy | 143.51 | 2,790 | 400,393 | 9,041 | Jun 04 04:25 PM |
| BORIO LUCIANA | Director | Jun 03 '26 | Sale | 143.27 | 418 | 59,887 | 4,329 | Jun 04 04:23 PM |
| WEATHERMAN ELIZABETH H | Director | Jun 03 '26 | Buy | 144.20 | 3,450 | 497,490 | 10,352 | Jun 03 04:19 PM |
| BORIO LUCIANA | Director | Jun 03 '26 | Proposed Sale | 143.26 | 418 | 59,885 | Jun 03 03:07 PM | |
| MINOGUE MICHAEL R | Director | Feb 25 '26 | Buy | 246.23 | 2,030 | 499,847 | 17,483 | Feb 26 07:05 AM |
| McEvoy Ashley | President and CEO | Feb 20 '26 | Buy | 239.35 | 4,300 | 1,029,205 | 13,916 | Feb 23 08:14 AM |
| Frederick Wayne A.I. | Director | Dec 15 '25 | Sale | 293.09 | 1,851 | 542,510 | 2,158 | Dec 16 04:04 PM |
| Frederick Wayne A.I. | Director | Dec 15 '25 | Proposed Sale | 293.09 | 1,851 | 542,500 | Dec 15 03:03 PM | |
| STONESIFER TIMOTHY C. | Director | Dec 05 '25 | Buy | 311.73 | 962 | 299,884 | 4,591 | Dec 08 04:02 PM |
| Manea Dan | Former Officer | Nov 26 '25 | Proposed Sale | 326.64 | 4,475 | 1,461,716 | Nov 26 04:31 PM | |
| Manea Dan | Former Officer | Nov 24 '25 | Proposed Sale | 340.95 | 2,306 | 786,228 | Nov 24 04:06 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 687.42B |
| VOO | Vanguard S&P 500 ETF | AUM: 1054.75B |
| RSP | Invesco S&P 500 Equal Weight ETF | AUM: 104.94B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 79.59B |
| IVV | iShares Core S&P 500 ETF | AUM: 871.38B |
| SPY | SPDR S&P 500 ETF Trust | AUM: 793.23B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.34B |
| XLV | State Street Health Care Select Sector SPDR ETF | AUM: 50.35B |
| IWP | iShares Russell Mid-Cap Growth ETF | AUM: 18.09B |
| IHI | iShares U.S. Medical Devices ETF | AUM: 4.07B |
News
latest 14 of 206- For World Diabetes Day, Insulet Launches "Give Yourself the Freedom to" Campaign, Encouraging People with Diabetes to Prioritize Their Well-Being (Business Wire)
- Insulet Beats On Record Margins, But A Pre-Cut 2027 Outlook And Stalling U.S. Patient Starts Shift The Story (Earnings Whispers) +6.56%
- Insulet: Q3 Earnings Snapshot (Associated Press)
- Insulet Reports Third Quarter 2026 Results (Business Wire)
- Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London (Business Wire)
- Loading…
- Insulet Must Show Its Type 2 Retention Problem Is Contained After Guidance Cut (Earnings Whispers)
- 7 healthcare stocks that stand out as investors pay up for the sector (MarketWatch)
- Insulet Announces Omnipod Discover Now Available in U.S. (Business Wire)
- Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls (The Fly)
- Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026 (Business Wire)
- Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum (Business Wire)
- Why Pay More For Stryker When BSX Stock Is On Sale? (Trefis)
- Beta Bionics insulin patch pump gets FDA nod (MedTech Dive)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-11-04 | 1.990 | 1.587 | 2.030 | 842 | 832.63 | 24 |
| 2026Q2 | 2026-08-05 | 1.660 | 1.468 | 1.066 | 801.7 | 787.39 | 22 |
| 2026Q1 | 2026-05-06 | 1.420 | 1.199 | 1.298 | 761.7 | 729.89 | 21 |
| 2025Q4 | 2026-02-18 | 1.550 | 1.468 | 1.441 | 783.8 | 768.97 | 23 |
| 2025Q3 | 2025-11-06 | 1.240 | 1.140 | 1.240 | 706.3 | 678.41 | 21 |
| 2025Q2 | 2025-08-07 | 1.170 | 0.920 | 0.319 | 649.1 | 614.2 | 22 |
| 2025Q1 | 2025-05-08 | 1.020 | 0.790 | 0.502 | 569 | 543.3 | 19 |
| 2024Q4 | 2025-02-20 | 1.150 | 1.004 | 1.386 | 597.5 | 582.54 | 16 |
| 2024Q3 | 2024-11-07 | 0.900 | 0.778 | 1.079 | 543.9 | 519.51 | 18 |
| 2024Q2 | 2024-08-08 | 2.590 | 0.564 | 2.589 | 488.5 | 488 | 19 |
| 2024Q1 | 2024-05-09 | 0.730 | 0.401 | 0.734 | 441.7 | 424.05 | 18 |
| 2023Q4 | 2024-02-22 | 1.440 | 0.653 | 1.479 | 509.8 | 461.26 | 19 |
| 2023Q3 | 2023-11-02 | 0.740 | 0.403 | 0.705 | 432.7 | 414.32 | 19 |
| 2023Q2 | 2023-08-08 | 0.390 | 0.263 | 0.389 | 396.5 | 385.26 | 17 |
| 2023Q1 | 2023-05-04 | 0.340 | 0.106 | 0.340 | 358.1 | 330.91 | 17 |
| 2022Q4 | 2023-02-23 | 0.240 | 0.219 | 0.243 | 369.7 | 332.45 | 16 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2019FY | 0.190 | 0.223 | 0.186 | 738.2 | 728.26 |
| 2020FY | 0.100 | 0.325 | 0.103 | 904.4 | 891.32 |
| 2021FY | 0.240 | 0.129 | 0.245 | 1,099 | 1,092 |
| 2022FY | 0.070 | 0.416 | 0.066 | 1,305 | 1,269 |
| 2023FY | 2.940 | 1.990 | 2.943 | 1,697 | 1,648 |
| 2024FY | 3.240 | 3.209 | 5.784 | 2,072 | 2,057 |
| 2025FY | 4.970 | 4.883 | 3.480 | 2,708 | 2,693 |
| 2026FY | - | 6.809 | - | - | 3,306 |
| 2027FY | - | 8.013 | - | - | 3,698 |
| 2028FY | - | 9.522 | - | - | 4,129 |
| 2029FY | - | 10.734 | - | - | 4,595 |
| 2030FY | - | 12.305 | - | - | 4,964 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-05 | 22 | 7 | 2 | 899.76 | 875.77 | 915 |
| 2026Q4 | S | 2026-11-04 | 22 | 6 | 3 | 899.14 | 875.77 | 915 |
| 2026Q4 | S | 2026-10-27 | 21 | 0 | 2 | 893.65 | 874.1 | 901.73 |
| 2026Q4 | S | 2026-10-26 | 21 | 0 | 3 | 893.65 | 874.1 | 901.73 |
| 2026Q4 | S | 2026-10-25 | 20 | 0 | 2 | 893.53 | 874.1 | 901.73 |
| 2026Q4 | S | 2026-10-19 | 20 | 0 | 3 | 893.53 | 874.1 | 901.73 |
| 2026Q4 | S | 2026-10-18 | 20 | 0 | 18 | 893.53 | 874.1 | 901.73 |
| 2026Q4 | S | 2026-10-09 | 20 | 0 | 19 | 893.53 | 874.1 | 901.73 |
| 2026Q4 | S | 2026-10-08 | 20 | 0 | 19 | 893.62 | 874.1 | 903 |
| 2026Q4 | S | 2026-09-29 | 20 | 0 | 19 | 893.63 | 874.1 | 903 |
| 2026Q4 | S | 2026-09-23 | 20 | 0 | 19 | 893.43 | 874.1 | 903 |
| 2026Q4 | S | 2026-09-11 | 20 | 0 | 19 | 894.07 | 874.1 | 906.3 |
| 2026Q4 | S | 2026-08-31 | 21 | 0 | 19 | 895.72 | 874.1 | 928.7 |
| 2026Q4 | S | 2026-08-13 | 22 | 0 | 20 | 895.69 | 874.1 | 928.7 |
Estimate history
| EPS, annual | -0.46 | 0.054 | 0.186 | 0.103 | 0.245 | 0.066 | 2.943 | 5.784 | 3.479 | 5.8349 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | 1.079 | 1.386 | 0.502 | 0.319 | 1.24 | 1.441 | 1.298 | 1.066 | 2.03 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Sales, annual | 463.768 | 563.823 | 738.2 | 904.4 | 1098.8 | 1305.3 | 1697.1 | 2071.6 | 2708.1 | 3189.2 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 543.9 | 597.5 | 569 | 649.1 | 706.3 | 783.8 | 761.7 | 801.7 | 842 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Shares, annual | 58.319 | 59.189 | 62.685 | 66.017 | 69.179 | 69.511 | 69.907 | 70.196 | 70.391 | 69.367 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 70.142 | 70.196 | 70.362 | 70.391 | 70.346 | 70.391 | 69.264 | 69.351 | 69.367 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,189.20 | 2,708.10 | 2,071.60 | 1,697.10 | 1,305.30 | 1,098.80 | 904.40 | 738.20 | 563.82 |
| Cost of Goods Sold Incl. D&A | 863.40 | 753.70 | 611.60 | 528.80 | 419.90 | 342.80 | 328.80 | 260.60 | 195.46 |
| Gross Profit | 2,325.80 | 1,954.40 | 1,460.00 | 1,168.30 | 885.40 | 756.00 | 575.60 | 477.60 | 368.37 |
| Selling, General and Administrative Excl. Other | 1,684.10 | 1,455.60 | 1,127.00 | 929.70 | 760.80 | 619.30 | 513.40 | 427.60 | 327.25 |
| Research and Development | 360.30 | 301.10 | 219.60 | 205.00 | 180.20 | 160.10 | 146.80 | 129.70 | 88.61 |
| Other Operating Expense | 54.30 | 25.00 | 24.10 | 18.60 | 87.00 | 10.70 | 10.70 | 0.00 | 0.00 |
| Operating Income | 587.40 | 473.80 | 308.90 | 220.00 | 37.60 | 126.00 | 51.50 | 50.00 | 41.11 |
| Interest Expense | 64.00 | 79.70 | 42.70 | 36.20 | 36.50 | 61.70 | 48.10 | 34.60 | 28.90 |
| Unusual Expense | -0.30 | 123.50 | 0.00 | 0.00 | 0.00 | 42.40 | 0.00 | 6.90 | 13.69 |
| Net Income Before Taxes | 549.10 | 339.50 | 300.20 | 214.60 | 9.80 | 20.50 | 9.70 | 14.50 | 5.23 |
| Income Taxes | 120.20 | 92.40 | -118.10 | 8.30 | 5.20 | 3.70 | 2.90 | 2.90 | 1.93 |
| Consolidated Net Income | 428.80 | 247.10 | 418.30 | 206.30 | 4.60 | 16.80 | 6.80 | 11.60 | 3.29 |
| Net Income From Continuing Operations | 428.80 | 247.10 | 418.30 | 206.30 | 4.60 | 16.80 | 6.80 | 11.60 | 3.29 |
| Net Income | 428.80 | 247.10 | 418.30 | 206.30 | 4.60 | 16.80 | 6.80 | 11.60 | 3.29 |
| EPS (Recurring) | 5.87 | 4.68 | 5.78 | 2.94 | 0.07 | 0.68 | 0.10 | 0.26 | 0.21 |
| EPS (Basic, Before Extraordinaries) | 6.15 | 3.51 | 5.97 | 2.96 | 0.07 | 0.25 | 0.10 | 0.19 | 0.06 |
| EPS (Diluted) | 5.83 | 3.48 | 5.78 | 2.94 | 0.07 | 0.24 | 0.10 | 0.19 | 0.05 |
| EBITDA | 718.80 | 586.90 | 407.90 | 292.80 | 100.80 | 183.40 | 106.90 | 77.90 | 56.76 |
| Non-Operating Income (Expense) | 25.40 | 68.90 | 34.00 | 30.80 | 8.70 | -1.40 | 6.30 | 6.00 | 6.71 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 64.54 | 49.45 | 54.75 | 38.16 | 32.31 | 25.11 | 26.21 | 20.95 | 29.64 |
| Price To Earnings Ratio | 25.37 | 25.37 | 44.39 | 129.42 | 1,243.73 | 1,185.70 | 2,543.58 | 918.95 | 1,649.06 |
| Price To Sales Ratio | 2.84 | 7.55 | 9.31 | 9.41 | 15.77 | 16.61 | 18.64 | 14.45 | 8.58 |
| Gross Margin | 72.93 | 72.17 | 70.48 | 68.84 | 67.83 | 68.80 | 63.64 | 64.70 | 65.33 |
| Operating Margin | 18.42 | 17.50 | 14.91 | 12.96 | 2.88 | 11.47 | 5.69 | 6.77 | 7.29 |
| Net Margin | 13.45 | 9.12 | 20.19 | 12.16 | 0.35 | 1.53 | 0.75 | 1.57 | 0.58 |
| Shares Outstanding | 69.37 | 70.39 | 70.20 | 69.91 | 69.51 | 69.18 | 66.02 | 62.69 | 59.19 |
| Market Capitalization | 10,271.07 | 10,271.07 | 18,312.70 | 15,151.19 | 20,445.00 | 18,350.13 | 16,853.15 | 10,583.93 | 4,685.99 |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 842.00 | 801.70 | 761.70 | 783.80 | 706.30 | 649.10 | 569.00 | 597.50 |
| Cost of Goods Sold Incl. D&A | 206.20 | 220.00 | 223.70 | 213.50 | 192.80 | 192.70 | 154.80 | 163.00 |
| Gross Profit | 635.80 | 581.70 | 538.00 | 570.30 | 513.50 | 456.40 | 414.20 | 434.50 |
| Selling, General and Administrative Excl. Other | 435.70 | 426.90 | 402.00 | 419.50 | 389.70 | 328.50 | 317.80 | 319.10 |
| Research and Development | 91.60 | 88.10 | 89.70 | 90.90 | 77.20 | 73.40 | 59.60 | 60.60 |
| Other Operating Expense | 10.30 | 25.30 | 14.20 | 4.50 | 6.10 | 6.80 | 7.60 | 6.10 |
| Operating Income | 189.80 | 129.50 | 121.80 | 146.30 | 117.70 | 121.10 | 88.80 | 109.30 |
| Interest Expense | 16.20 | 13.50 | 14.70 | 19.60 | 15.60 | 19.60 | 10.60 | 8.70 |
| Unusual Expense | 0.30 | -0.20 | -0.30 | -0.10 | -8.50 | 89.80 | 39.50 | 0.00 |
| Net Income Before Taxes | 177.20 | 118.70 | 113.00 | 140.20 | 122.80 | 28.40 | 48.10 | 111.30 |
| Income Taxes | 36.10 | 23.70 | 21.90 | 38.50 | 35.20 | 5.90 | 12.70 | 10.60 |
| Consolidated Net Income | 141.10 | 95.00 | 91.10 | 101.60 | 87.60 | 22.50 | 35.40 | 100.70 |
| Net Income From Continuing Operations | 141.10 | 95.00 | 91.10 | 101.60 | 87.60 | 22.50 | 35.40 | 100.70 |
| Net Income | 141.10 | 95.00 | 91.10 | 101.60 | 87.60 | 22.50 | 35.40 | 100.70 |
| EPS (Recurring) | 2.03 | 1.06 | 1.29 | 1.44 | 1.16 | 1.21 | 0.88 | 1.39 |
| EPS (Basic, Before Extraordinaries) | 2.03 | 1.37 | 1.30 | 1.44 | 1.24 | 0.32 | 0.50 | 1.44 |
| EPS (Diluted) | 2.03 | 1.07 | 1.30 | 1.44 | 1.24 | 0.32 | 0.50 | 1.39 |
| EBITDA | 224.80 | 162.80 | 154.30 | 176.90 | 145.60 | 148.90 | 115.60 | 135.80 |
| Non-Operating Income (Expense) | 3.90 | 2.50 | 5.60 | 13.40 | 12.20 | 16.80 | 9.40 | 10.70 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 16.20 | 15.56 | 16.83 | 15.96 | 13.19 | 5.92 | 14.38 | 15.80 |
| Price To Earnings Ratio | 25.37 | 35.44 | 59.94 | 82.47 | 93.96 | 56.54 | 45.37 | 44.39 |
| Price To Sales Ratio | 2.84 | 3.46 | 5.08 | 7.42 | 8.65 | 9.41 | 8.85 | 9.34 |
| Gross Margin | 75.51 | 72.56 | 70.63 | 72.76 | 72.70 | 70.31 | 72.79 | 72.72 |
| Operating Margin | 22.54 | 16.15 | 15.99 | 18.67 | 16.66 | 18.66 | 15.61 | 18.29 |
| Net Margin | 16.76 | 11.85 | 11.96 | 12.96 | 12.40 | 3.47 | 6.22 | 16.85 |
| Shares Outstanding | 69.37 | 69.35 | 69.26 | 70.39 | 70.35 | 70.39 | 70.36 | 70.20 |
| Market Capitalization | 10,271.07 | 10,545.55 | 14,771.85 | 19,995.40 | 21,732.28 | 22,110.39 | 18,442.08 | 18,312.70 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 716.10 | 953.40 | 704.20 | 674.70 | 791.60 | 947.60 | 376.10 | 288.95 | 440.06 |
| Short Term Receivables | 516.90 | 365.50 | 359.70 | 205.60 | 161.00 | 83.80 | 82.80 | 76.67 | 53.37 |
| Inventories | 452.60 | 430.40 | 402.60 | 346.80 | 303.20 | 154.30 | 101.00 | 71.41 | 33.79 |
| Other Current Assets | 203.10 | 121.90 | 99.80 | 71.70 | 60.70 | 52.00 | 21.60 | 16.98 | 9.95 |
| Total Current Assets | 1,888.70 | 1,871.20 | 1,566.30 | 1,298.80 | 1,316.50 | 1,237.70 | 581.50 | 454.01 | 537.17 |
| Net Property, Plant & Equipment | 863.20 | 759.80 | 692.80 | 625.90 | 546.40 | 493.60 | 415.50 | 258.38 | 107.86 |
| Total Investments and Advances | 20.10 | 0.00 | 0.00 | 15.00 | 19.30 | 14.80 | 58.40 | 140.78 | 125.55 |
| Intangible Assets | 168.70 | 150.00 | 150.40 | 127.20 | 76.40 | 68.50 | 53.00 | 50.03 | 44.19 |
| Deferred Tax Assets | 82.40 | 141.80 | - | - | - | - | - | - | - |
| Other Assets | 167.30 | 164.90 | 178.70 | 184.20 | 90.20 | 58.30 | 34.50 | 25.54 | 1.97 |
| Total Assets | 3,190.40 | 3,087.70 | 2,588.20 | 2,251.10 | 2,048.80 | 1,872.90 | 1,142.90 | 928.74 | 816.74 |
| Short Term Debt Incl. Current Port. of LT Debt | 22.20 | 85.90 | 52.90 | 31.10 | 30.10 | 20.50 | 3.60 | 0.00 | 0.00 |
| Accounts Payable | 75.00 | 19.80 | 19.20 | 30.80 | 37.70 | 54.10 | 54.50 | 25.50 | 24.41 |
| Other Current Liabilities | 582.90 | 422.70 | 379.10 | 302.80 | 161.00 | 133.20 | 99.60 | 90.16 | 61.61 |
| Total Current Liabilities | 680.10 | 528.40 | 451.20 | 364.70 | 228.80 | 207.80 | 157.70 | 115.66 | 86.03 |
| Long Term Debt | 979.70 | 1,336.10 | 1,395.90 | 1,401.70 | 1,256.40 | 1,055.70 | 902.30 | 591.98 | 566.17 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.68 | 0.00 |
| Other Liabilities | 15.40 | 11.60 | 8.40 | 8.30 | 7.30 | 5.80 | 7.00 | 5.33 | 6.03 |
| Total Liabilities | 1,675.20 | 1,876.10 | 1,855.50 | 1,774.70 | 1,492.50 | 1,269.30 | 1,067.00 | 716.64 | 658.23 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 1,515.20 | 1,211.60 | 732.70 | 476.40 | 556.30 | 603.60 | 75.90 | 212.10 | 158.52 |
| Total Shareholders Equity | 1,515.20 | 1,211.60 | 732.70 | 476.40 | 556.30 | 603.60 | 75.90 | 212.10 | 158.52 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 1,515.20 | 1,211.60 | 732.70 | 476.40 | 556.30 | 603.60 | 75.90 | 212.10 | 158.52 |
| Total Liabilities & Stockholders Equity | 3,190.40 | 3,087.70 | 2,588.20 | 2,251.10 | 2,048.80 | 1,872.90 | 1,142.90 | 928.74 | 816.74 |
| Book Value Per Share | 21.53 | 17.26 | 10.48 | 6.85 | 8.04 | 9.14 | 1.21 | 3.58 | 2.72 |
| Tangible Book Value Per Share | 19.13 | 15.12 | 8.33 | 5.02 | 6.94 | 8.11 | 0.37 | 2.74 | 1.96 |
| Full-Time Employees | 5,400 | 3,900 | 3,000 | 2,600 | 2,300 | 1,900 | 1,350 | 1,169 | 857 |
| Price to Book Ratio | 6.50 | 16.38 | 24.94 | 47.76 | 33.09 | 27.96 | 141.39 | 22.14 | 54.04 |
| Return on Assets | 7.87 | 14.74 | 8.53 | 0.21 | 0.86 | 0.45 | 1.12 | 0.38 | -4.21 |
| Return on Equity | 18.12 | 43.03 | 34.12 | 0.89 | 2.90 | 2.00 | 8.06 | 1.78 | -24.21 |
| Return on Invested Capital | 9.90 | 16.42 | 9.69 | 0.24 | 0.93 | 0.41 | 1.19 | 0.41 | -3.70 |
| Quick Ratio | 2.11 | 2.73 | 2.58 | 2.61 | 4.43 | 5.21 | 3.05 | 3.31 | 5.85 |
| Current Ratio | 2.78 | 3.54 | 3.47 | 3.56 | 5.75 | 5.96 | 3.69 | 3.93 | 6.24 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 428.70 | 247.10 | 418.30 | 206.30 | 4.60 | 16.80 | 6.80 | 11.60 | 3.29 |
| Depreciation | 105.50 | 90.40 | 80.80 | 72.80 | 63.20 | 57.40 | 55.40 | 27.90 | 15.65 |
| Other Funds (Non Cash) | 89.60 | 192.70 | 85.10 | 56.90 | 53.70 | 121.30 | 85.20 | 78.60 | 69.78 |
| Funds from Operations | 671.80 | 592.40 | 447.30 | 336.00 | 121.50 | 195.50 | 147.40 | 118.10 | 88.72 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -162.80 | -23.10 | -17.00 | -190.60 | -2.50 | -263.60 | -63.40 | -19.70 | -52.82 |
| Cash from Operating Activities | 509.00 | 569.30 | 430.30 | 145.40 | 119.00 | -68.10 | 84.00 | 98.40 | 35.90 |
| Capital Expenditures | -276.40 | -219.40 | -134.00 | -109.20 | -157.30 | -122.70 | -166.50 | -170.90 | -162.35 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | -3.00 | -26.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -5.00 | 0.00 | -12.20 | -7.20 | -7.80 | 40.00 | 180.50 | 97.30 | -22.15 |
| Purchase of Investments | -5.00 | 0.00 | -12.20 | -7.20 | -7.80 | 0.00 | -37.90 | -150.60 | -191.42 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.00 | 218.40 | 247.90 | 169.27 |
| Other Uses | -3.30 | -3.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -284.80 | -222.70 | -146.20 | -119.40 | -191.10 | -82.70 | 14.00 | -73.60 | -184.50 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -280.80 | -25.70 | 20.10 | 26.90 | 16.30 | 23.50 | 509.20 | -34.50 | 15.81 |
| Repurchase of Common Pref Stock | -300.00 | -59.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 19.20 | 33.90 | 20.10 | 26.90 | 16.30 | 23.50 | 509.20 | -34.50 | 15.81 |
| Proceedsfrom Stock Options | 16.70 | 14.90 | 11.90 | 10.60 | 0.00 | 0.00 | 477.50 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -95.80 | -708.10 | -17.90 | -27.00 | -39.80 | 45.40 | 128.30 | 116.60 | -6.70 |
| Change in Long Term Debt | -79.90 | -695.60 | -28.60 | -27.00 | -39.80 | 45.40 | 128.30 | 116.60 | -6.70 |
| Issuance of Long Term Debt | 30.00 | 456.20 | 130.00 | 0.00 | 0.00 | 532.60 | 128.30 | 780.20 | 0.00 |
| Reduction of Long Term Debt | -109.90 | -1,151.80 | -158.60 | -27.00 | -39.80 | -487.20 | 0.00 | -663.60 | -6.70 |
| Net Financing Active Other Cash Flow | -17.90 | 138.50 | -7.60 | -13.20 | -16.80 | -28.20 | -32.00 | -8.60 | -17.78 |
| Other Financing Activities Uses | -17.70 | -25.90 | -7.60 | -13.20 | -16.80 | -28.20 | -32.00 | -8.60 | -17.78 |
| Cash from Financing Activities | -394.40 | -595.30 | -28.10 | -13.30 | -40.30 | 40.70 | 605.50 | 73.50 | -8.66 |
| Exchange Rate Effect | -2.80 | 11.50 | -6.80 | 1.80 | -4.30 | -5.50 | 4.80 | 1.50 | -1.40 |
| Net Change in Cash | -173.00 | -237.20 | 249.20 | 14.50 | -116.70 | -115.60 | 708.30 | 99.80 | -158.67 |
| Free Cash Flow | 260.00 | 377.70 | 305.40 | 69.80 | -3.90 | -180.00 | -45.00 | -65.30 | -126.45 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow | 34.87 | 54.10 | 63.16 | 228.90 | - | - | - | - | - |
| Deferred Taxes & Investment Tax Credit | - | 62.20 | -136.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 584.40 | 534.90 | 480.40 | 716.10 | 757.40 | 1,121.60 |
| Short Term Receivables | 689.00 | 588.70 | 544.70 | 516.90 | 462.20 | 444.50 |
| Inventories | 552.10 | 484.80 | 462.50 | 452.60 | 446.30 | 446.90 |
| Other Current Assets | 188.50 | 213.50 | 196.50 | 203.10 | 169.10 | 244.10 |
| Total Current Assets | 2,013.90 | 1,821.90 | 1,684.10 | 1,888.70 | 1,835.10 | 2,257.10 |
| Net Property, Plant & Equipment | 918.60 | 858.60 | 830.40 | 863.20 | 724.10 | 720.40 |
| Total Investments and Advances | 24.10 | 19.10 | 19.10 | 20.10 | 19.10 | 19.10 |
| Intangible Assets | 166.40 | 166.70 | 166.80 | 168.70 | 156.60 | 154.00 |
| Deferred Tax Assets | - | - | - | 82.40 | 100.90 | - |
| Other Assets | 292.10 | 298.90 | 286.90 | 167.30 | 193.50 | 318.60 |
| Total Assets | 3,415.10 | 3,165.10 | 2,987.20 | 3,190.40 | 3,029.30 | 3,469.20 |
| Short Term Debt Incl. Current Port. of LT Debt | 19.10 | 18.90 | 18.60 | 22.20 | 96.40 | 478.40 |
| Accounts Payable | 162.20 | 123.30 | 149.80 | 75.00 | 48.20 | 96.10 |
| Other Current Liabilities | 633.10 | 602.00 | 519.10 | 582.90 | 503.10 | 435.60 |
| Total Current Liabilities | 814.40 | 744.20 | 687.50 | 680.10 | 647.70 | 1,010.10 |
| Long Term Debt | 943.00 | 929.50 | 929.50 | 979.70 | 934.90 | 939.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 78.60 | 69.20 | 67.70 | 15.40 | 62.60 | 57.10 |
| Total Liabilities | 1,836.00 | 1,742.90 | 1,684.70 | 1,675.20 | 1,645.20 | 2,006.20 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 1,579.10 | 1,422.20 | 1,302.60 | 1,515.20 | 1,384.10 | 1,462.90 |
| Total Shareholders Equity | 1,579.10 | 1,422.20 | 1,302.60 | 1,515.20 | 1,384.10 | 1,462.90 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 1,579.10 | 1,422.20 | 1,302.60 | 1,515.20 | 1,384.10 | 1,462.90 |
| Total Liabilities & Stockholders Equity | 3,415.10 | 3,165.10 | 2,987.30 | 3,190.40 | 3,029.30 | 3,469.10 |
| Book Value Per Share | 22.76 | 20.51 | 18.81 | 21.53 | 19.68 | 20.78 |
| Tangible Book Value Per Share | 20.37 | 18.10 | 16.40 | 19.13 | 17.45 | 18.59 |
| Full-Time Employees | - | - | - | 5,400 | - | - |
| Price to Book Ratio | 6.50 | 8.10 | 9.75 | 14.45 | 14.86 | 16.61 |
| Return on Assets | 13.31 | 11.31 | 9.31 | 7.87 | 8.13 | 7.44 |
| Return on Equity | 28.94 | 26.02 | 23.00 | 18.12 | 19.68 | 19.18 |
| Return on Invested Capital | 5.59 | 4.04 | 4.08 | 4.07 | 3.78 | 0.94 |
| Quick Ratio | 1.79 | 1.80 | 1.78 | 2.11 | 2.14 | 1.79 |
| Current Ratio | 2.47 | 2.45 | 2.45 | 2.78 | 2.83 | 2.23 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | 141.00 | 95.00 | 91.10 | 101.60 | 87.60 | 22.50 |
| Depreciation | 28.20 | 26.70 | 26.20 | 24.40 | 22.00 | 22.30 |
| Other Funds (Non Cash) | 23.80 | 20.60 | 21.90 | 23.30 | 6.10 | 91.60 |
| Funds from Operations | 206.30 | 150.50 | 146.20 | 168.80 | 151.40 | 143.40 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -82.90 | -62.00 | -32.40 | 14.50 | -25.70 | 53.10 |
| Cash from Operating Activities | 123.40 | 88.50 | 113.80 | 183.30 | 125.70 | 196.50 |
| Capital Expenditures | -61.90 | -37.30 | -27.80 | -149.40 | -31.10 | -23.20 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -5.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | -5.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | -3.30 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -66.90 | -37.40 | -27.70 | -152.80 | -31.00 | -23.20 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.20 | 9.00 | -299.60 | 9.60 | -24.90 | -36.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | -300.00 | 0.00 | -29.50 | -30.10 |
| Sale of Common Pref Stock | 0.20 | 9.00 | 0.40 | 9.60 | 4.60 | -5.90 |
| Proceedsfrom Stock Options | 0.00 | 8.90 | 0.00 | 7.80 | 0.00 | 7.10 |
| Issuance or Reduction of Debt, Net | -5.40 | -4.60 | -4.50 | -81.30 | -518.70 | -381.50 |
| Change in Long Term Debt | -4.60 | -4.60 | -4.50 | -66.20 | -517.80 | -385.00 |
| Issuance of Long Term Debt | 30.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Reduction of Long Term Debt | -34.60 | -4.60 | -4.50 | -66.20 | -517.80 | -385.10 |
| Net Financing Active Other Cash Flow | -0.70 | -0.50 | -15.70 | -1.00 | 86.70 | 74.00 |
| Other Financing Activities Uses | -0.70 | -0.50 | -15.70 | -0.80 | -2.20 | -1.70 |
| Cash from Financing Activities | -6.00 | 4.00 | -319.90 | -72.50 | -457.00 | -343.60 |
| Exchange Rate Effect | -1.10 | -0.50 | -1.90 | 0.70 | -1.90 | 8.90 |
| Net Change in Cash | 49.50 | 54.50 | -235.70 | -41.30 | -364.20 | -161.40 |
| Free Cash Flow | 66.30 | 56.00 | 89.50 | 48.20 | 100.10 | 177.90 |
| Price to Free Cash Flow | 34.87 | 35.97 | 35.44 | 53.18 | 51.50 | 56.15 |
Revenue breakdown
| Drug Delivery | 2024: 38.90M 2025: 34.10M |
|---|---|
| International Omnipod | 2024: 523.40M |
| Product, Omnipod | 2025: 2.67B |
| U.S. Omnipod | 2024: 1.51B |
| Consolidation, Policy | 2025: -100.00K |
| Non-US | 2024: 523.40M 2025: 754.30M |
| United States | 2024: 1.55B 2025: 1.95B |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 7.71% | 5.3M | 69.1M | 1.69M |
| 2026-10-15 | 8.15% | 5.6M | 69.1M | 1.69M |
| 2026-09-30 | 7.76% | 5.4M | 69.1M | 1.60M |
| 2026-09-15 | 7.36% | 5.1M | 69.1M | 1.67M |
| 2026-08-31 | 6.44% | 4.4M | 69.1M | 1.63M |
| 2026-08-14 | 5.35% | 3.7M | 69.1M | 1.58M |
| 2026-07-31 | 5.55% | 3.8M | 69.1M | 1.55M |
| 2026-07-15 | 6.74% | 4.6M | 69.0M | 1.55M |
| 2026-06-30 | 7.04% | 4.9M | 69.0M | 1.47M |
| 2026-06-15 | 7.11% | 4.9M | 68.9M | 1.32M |
| 2026-05-29 | 6.14% | 4.2M | 69.0M | 1.27M |
| 2026-05-15 | 4.37% | 3.0M | 69.0M | 1.22M |
| 2026-04-30 | 4.30% | 3.0M | 69.0M | 1.07M |
| 2026-04-15 | 3.92% | 2.7M | 69.0M | 1.04M |
| 2026-03-31 | 4.35% | 3.0M | 70.1M | 1.01M |
| 2026-03-13 | 3.65% | 2.6M | 70.1M | 963.38K |
| 2026-02-27 | 4.02% | 2.8M | 70.1M | 893.43K |
| 2026-02-13 | 2.16% | 1.5M | 70.1M | 837.70K |
| 2026-01-30 | 2.76% | 1.9M | 70.1M | 786.85K |
| 2026-01-15 | 2.82% | 2.0M | 70.1M | 666.93K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 85.00 | 59.20 | 65.20 | 0.00 | 2.606 | 0.00 | 0.00 | 0.995 | -0.033 | 0.003 |
| call | 90.00 | 54.20 | 60.90 | 0.00 | 2.806 | 0.00 | 0.00 | 0.995 | -0.034 | 0.003 |
| call | 95.00 | 48.10 | 55.30 | 0.00 | 2.395 | 0.00 | 0.00 | 0.994 | -0.034 | 0.004 |
| call | 100 | 44.90 | 50.20 | 43.54 | 2.058 | 2.00 | 0.00 | 0.989 | -0.051 | 0.007 |
| call | 105 | 39.30 | 45.30 | 0.00 | 1.805 | 0.00 | 0.00 | 0.962 | -0.149 | 0.019 |
| call | 110 | 34.40 | 40.40 | 0.00 | 1.641 | 0.00 | 0.00 | 0.958 | -0.146 | 0.021 |
| call | 115 | 29.50 | 35.50 | 0.00 | 1.489 | 0.00 | 0.00 | 0.906 | -0.298 | 0.039 |
| call | 120 | 24.50 | 30.50 | 19.20 | 1.358 | 1.00 | 0.00 | 0.893 | -0.285 | 0.043 |
| call | 125 | 20.00 | 25.40 | 17.80 | 1.079 | 1.00 | 0.00 | 0.879 | -0.271 | 0.047 |
| call | 130 | 15.50 | 20.30 | 16.61 | 0.912 | 3.00 | 0.00 | 0.858 | -0.252 | 0.053 |
| call | 135 | 10.90 | 15.70 | 13.00 | 0.874 | 19.00 | 0.00 | 0.797 | -0.278 | 0.066 |
| call | 140 | 6.40 | 12.90 | 13.83 | 0.881 | 51.00 | 0.00 | 0.689 | -0.407 | 0.083 |
| call | 145 | 3.10 | 7.10 | 6.30 | 0.614 | 134 | 0.00 | 0.588 | -0.357 | 0.091 |
| call | 150 | 0.70 | 7.30 | 3.80 | 0.876 | 298 | 0.00 | 0.483 | -0.452 | 0.093 |
| call | 155 | 1.00 | 3.10 | 2.25 | 0.637 | 1,355 | 0.00 | 0.352 | -0.338 | 0.086 |
| call | 160 | 0.30 | 1.80 | 1.19 | 0.629 | 152 | 0.00 | 0.239 | -0.269 | 0.072 |
| call | 165 | 0.00 | 1.50 | 1.12 | 0.700 | 1,486 | 0.00 | 0.178 | -0.237 | 0.061 |
| call | 170 | 0.00 | 1.50 | 0.35 | 0.828 | 293 | 0.00 | 0.157 | -0.257 | 0.056 |
| call | 175 | 0.00 | 1.50 | 0.30 | 0.920 | 38.00 | 0.00 | 0.144 | -0.271 | 0.053 |
| call | 180 | 0.00 | 1.50 | 0.21 | 1.045 | 483 | 0.00 | 0.132 | -0.287 | 0.050 |
| call | 185 | 0.00 | 1.50 | 0.61 | 1.122 | 11.00 | 0.00 | 0.124 | -0.297 | 0.048 |
| call | 190 | 0.00 | 1.50 | 0.95 | 0.636 | 18.00 | 0.00 | 0.010 | -0.021 | 0.006 |
| call | 195 | 0.00 | 1.50 | 0.00 | 0.693 | 0.00 | 0.00 | 0.009 | -0.021 | 0.006 |
| call | 200 | 0.00 | 1.70 | 0.00 | 1.388 | 0.00 | 0.00 | 0.105 | -0.327 | 0.043 |
| put | 85.00 | 0.00 | 0.60 | 0.00 | 1.401 | 0.00 | 0.00 | -0.005 | -0.024 | 0.003 |
| put | 90.00 | 0.00 | 0.05 | 0.05 | 1.230 | 61.00 | 0.00 | -0.005 | -0.022 | 0.004 |
| put | 95.00 | 0.00 | 0.05 | 0.05 | 1.108 | 56.00 | 0.00 | -0.006 | -0.022 | 0.004 |
| put | 100 | 0.00 | 0.10 | 0.10 | 1.127 | 12.00 | 0.00 | -0.011 | -0.040 | 0.007 |
| put | 105 | 0.00 | 1.50 | 0.22 | 1.310 | 11.00 | 0.00 | -0.038 | -0.138 | 0.019 |
| put | 110 | 0.00 | 0.50 | 0.35 | 1.161 | 15.00 | 0.00 | -0.042 | -0.134 | 0.021 |
| put | 115 | 0.00 | 1.50 | 0.80 | 1.326 | 87.00 | 0.00 | -0.095 | -0.285 | 0.039 |
| put | 120 | 0.05 | 1.50 | 0.41 | 1.148 | 73.00 | 0.00 | -0.108 | -0.270 | 0.043 |
| put | 125 | 0.05 | 1.50 | 0.84 | 0.978 | 33.00 | 0.00 | -0.124 | -0.254 | 0.048 |
| put | 130 | 0.05 | 1.50 | 1.67 | 0.834 | 24.00 | 0.00 | -0.142 | -0.238 | 0.053 |
| put | 135 | 0.35 | 2.00 | 1.06 | 0.727 | 475 | 0.00 | -0.203 | -0.263 | 0.066 |
| put | 140 | 1.00 | 4.40 | 2.30 | 0.845 | 35.00 | 0.00 | -0.323 | -0.393 | 0.084 |
| put | 145 | 0.70 | 5.70 | 3.08 | 0.774 | 55.00 | 0.00 | -0.403 | -0.341 | 0.090 |
| put | 150 | 4.70 | 9.30 | 8.24 | 0.865 | 1,244 | 0.00 | -0.517 | -0.435 | 0.093 |
| put | 155 | 6.10 | 12.60 | 6.00 | 0.934 | 203 | 0.00 | -0.602 | -0.409 | 0.090 |
| put | 160 | 11.50 | 18.00 | 0.00 | 1.165 | 0.00 | 0.00 | -0.746 | -0.260 | 0.075 |
| put | 165 | 16.00 | 21.40 | 9.86 | 1.141 | 7.00 | 0.00 | -0.820 | -0.217 | 0.061 |
| put | 170 | 20.30 | 26.10 | 0.00 | 1.234 | 0.00 | 0.00 | -0.841 | -0.219 | 0.059 |
| put | 175 | 25.00 | 31.00 | 29.38 | 1.380 | 1.00 | 0.00 | -0.855 | -0.252 | 0.053 |
| put | 180 | 29.90 | 35.90 | 0.00 | 1.478 | 0.00 | 0.00 | -0.867 | -0.265 | 0.050 |
| put | 185 | 34.90 | 40.90 | 0.00 | 1.594 | 0.00 | 0.00 | -0.876 | -0.277 | 0.048 |
| put | 190 | 39.20 | 47.20 | 0.00 | 1.866 | 0.00 | 0.00 | -0.884 | -0.289 | 0.045 |
| put | 195 | 44.90 | 50.90 | 0.00 | 1.804 | 0.00 | 0.00 | -0.889 | -0.296 | 0.044 |
| put | 200 | 49.90 | 55.90 | 0.00 | 1.908 | 0.00 | 0.00 | -0.895 | -0.305 | 0.043 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-04 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-04 | 8-K | Current report | 2026-11-04 | SEC |
| 2026-10-27 | SCHEDULE 13G/A | SEC | ||
| 2026-10-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-01 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-09-21 | 8-K | Current report | 2026-09-21 | SEC |
| 2026-09-16 | 8-K | Current report | 2026-09-14 | SEC |
| 2026-09-10 | 8-K | Current report | 2026-09-03 | SEC |
| 2026-08-24 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-21 | SEC |
| 2026-08-06 | SCHEDULE 13G/A | SEC | ||
| 2026-08-05 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-05 | 8-K | Current report | 2026-08-05 | SEC |
| 2026-08-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-01 | SEC |
| 2026-07-07 | 4/A | 2026-06-30 | SEC | |
| 2026-07-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-01 | SEC |
| 2026-07-02 | 3 | Initial statement of beneficial ownership of securities | 2026-07-01 | SEC |
| 2026-07-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-30 | SEC |
| 2026-06-25 | 8-K | Current report | 2026-06-24 | SEC |
| 2026-06-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-03 | SEC |
| 2026-06-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-03 | SEC |
| 2026-06-03 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-06-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-03 | SEC |
| 2026-05-28 | SD | Specialized Disclosure Report | SEC | |
| 2026-05-26 | 8-K | Current report | 2026-05-26 | SEC |
| 2026-05-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-20 | SEC |
| 2026-05-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-20 | SEC |
| 2026-05-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-20 | SEC |
| 2026-05-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-20 | SEC |
| 2026-05-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-20 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 162.22K | 1 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 897.88K | 2 | 59.89K | 1 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 1.53M | 2 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 299.88K | 1 | 542.51K | 1 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 9.66% |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.53% |
| STATE STREET CORP | 4.62% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.44% |
| AQR CAPITAL MANAGEMENT LLC | 3.54% |
| TWO SIGMA INVESTMENTS, LP | 2.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.66% |
| Invesco Ltd. | 2.45% |
| T. Rowe Price Investment Management, Inc. | 2.18% |
| MORGAN STANLEY | 2.14% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Advisor Floating Rate High Income Fund | 77.45% |
| American Beacon SiM High Yield Opportunities Fund | 36.88% |
| PIMCO High Yield Fund | 22.45% |
| BrandywineGLOBAL - HIGH YIELD FUND | 19.66% |
| iShares Broad USD High Yield Corporate Bond ETF | 14.04% |
| BrandywineGLOBAL - CORPORATE CREDIT FUND | 13.20% |
| MFS High Income Fund | 12.72% |
| Fidelity Total Bond Fund | 10.10% |
| BlackRock High Yield Portfolio | 9.77% |
| Fidelity Floating Rate Central Fund | 8.51% |
OakChart. PODD. Cached 15 minutes.